HASLEMERE HEALTHCARE LLPActive
Key figures
Like most small UK companies, HASLEMERE HEALTHCARE LLP does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Turnover | 1,269,784 | 1,318,479 | 1,460,067 | — | — |
| Profit for the year | — | -90,894 | -55,685 | — | — |
| Cash at bank and in hand | 2,712 | 3,028 | 2,354 | 2,393 | 2,598 |
| Total assets | 285,549 | 215,640 | 237,504 | 237,413 | 251,202 |
| Total liabilities | 432,469 | 504,983 | 511,551 | 521,858 | 478,668 |
| Net assets / total equity | -146,920 | -289,343 | -274,047 | -284,445 | -227,466 |
| Average number of employees | 14 | 14 | 13 | 15 | 14 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the LLP during the year was that of a pharmacy.
As described in the company's latest filed accounts.
Summary: HASLEMERE HEALTHCARE LLP
Company
HASLEMERE HEALTHCARE LLP is a limited liability partnership registered with Companies House under company number OC374887. It was incorporated on 1 May 2012. Its status is active. The registered office is in Croydon (CR0).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were −£227,466, up 20% on the previous year. Cash at bank and in hand was £2,598. Total assets were £251,202 and total liabilities £478,668. The company had an average of 14 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered. 1 of 4 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 15 May 2027.